These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9826177)

  • 1. Conformation analysis of eel calcitonin--comparison with the conformation of elcatonin.
    Ogawa K; Nishimura S; Uchiyama S; Kobayashi K; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1998 Oct; 257(2):331-6. PubMed ID: 9826177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of elcatonin in solution.
    Ogawa K; Nishimura S; Doi M; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1994 Jun; 222(2):659-66. PubMed ID: 8020504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational analysis of human calcitonin in solution.
    Ogawa K; Nishimura S; Doi M; Takashima H; Nishi Y; Yoshida T; Ohkubo T; Kobayashi Y
    J Pept Sci; 2006 Jan; 12(1):51-7. PubMed ID: 15948142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
    Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
    Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy.
    Hashimoto Y; Toma K; Nishikido J; Yamamoto K; Haneda K; Inazu T; Valentine KG; Opella SJ
    Biochemistry; 1999 Jun; 38(26):8377-84. PubMed ID: 10387083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of a human calcitonin analog elucidated by NMR and distance geometry calculations.
    Katahira R; Doi M; Kyogoku Y; Yamada-Nosaka A; Yamasaki K; Takai M; Kobayashi Y
    Int J Pept Protein Res; 1995 Apr; 45(4):305-11. PubMed ID: 7601602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations.
    Motta A; Pastore A; Goud NA; Castiglione Morelli MA
    Biochemistry; 1991 Oct; 30(43):10444-50. PubMed ID: 1931969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carbohydrate structure on biological activity of artificially N-glycosylated eel calcitonin.
    Tagashira M; Tanaka A; Hisatani K; Isogai Y; Hori M; Takamatsu S; Fujibayashi Y; Yamamoto K; Haneda K; Inazu T; Toma K
    Glycoconj J; 2001 Jun; 18(6):449-55. PubMed ID: 12084980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure and biological activity of recombinant salmon calcitonin S-sulfonated analog.
    Wang Y; Dou H; Cao C; Zhang N; Ma J; Mao J; Wu H
    Biochem Biophys Res Commun; 2003 Jun; 306(2):582-9. PubMed ID: 12804605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of salmon calcitonin.
    Meyer JP; Pelton JT; Hoflack J; Saudek V
    Biopolymers; 1991 Feb; 31(2):233-41. PubMed ID: 2043752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An NMR study of O-glycosylation induced structural changes in the alpha-helix of calcitonin.
    Tagashira M; Iijima H; Toma K
    Glycoconj J; 2002 Jan; 19(1):43-52. PubMed ID: 12652079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution conformation of an antibacterial peptide, sarcotoxin IA, as determined by 1H-NMR.
    Iwai H; Nakajima Y; Natori S; Arata Y; Shimada I
    Eur J Biochem; 1993 Oct; 217(2):639-44. PubMed ID: 8223606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment.
    Kohno T; Kobayashi K; Maeda T; Sato K; Takashima A
    Biochemistry; 1996 Dec; 35(50):16094-104. PubMed ID: 8973180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional solution structure of Cucurbita maxima trypsin inhibitor-V determined by NMR spectroscopy.
    Cai M; Gong Y; Kao JL; Krishnamoorthi R
    Biochemistry; 1995 Apr; 34(15):5201-11. PubMed ID: 7711040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of [Asu1 . 7]-eel calcitonin on glucagon-induced glycogenolysis in perfused rat liver.
    Mine T; Kimura S; Ogata E
    Horm Metab Res; 1983 Mar; 15(3):139-43. PubMed ID: 6303930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme immunoassay for elcatonin, a synthetic analogue of eel calcitonin, in plasma.
    Aikawa R; Ohyama K; Mori E; Hironaka K; Miyake M; Morishita M
    J Pharm Sci; 1985 Mar; 74(3):300-3. PubMed ID: 2409265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solution structure of recombinant hirudin and the Lys-47----Glu mutant: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study.
    Folkers PJ; Clore GM; Driscoll PC; Dodt J; Köhler S; Gronenborn AM
    Biochemistry; 1989 Mar; 28(6):2601-17. PubMed ID: 2567183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
    Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
    Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 1H NMR study of human calcitonin in solution.
    Motta A; Temussi PA; Wünsch E; Bovermann G
    Biochemistry; 1991 Mar; 30(9):2364-71. PubMed ID: 2001366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR structure determination of a novel conotoxin, [Pro 7,13] alpha A-conotoxin PIVA.
    Han KH; Hwang KJ; Kim SM; Kim SK; Gray WR; Olivera BM; Rivier J; Shon KJ
    Biochemistry; 1997 Feb; 36(7):1669-77. PubMed ID: 9048550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.